Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis.
about
Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for preventionPneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis RecommendationsConditions in subjects with rheumatic diseases: pulmonary manifestations of vasculitidesSmall vessel vasculitis of the lungIs newer safer? Adverse events associated with first-line therapies for ANCA-associated vasculitis and lupus nephritis.Pneumocystis jiroveci pneumonia in giant cell arteritis: A case series.Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literature.Wegener granulomatosisPrevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.Colonization by Pneumocystis jirovecii and its role in disease.Infection Risk and Safety of Corticosteroid Use.Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients.Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence?Lung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections.Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis.Getting the balance right: adverse events of therapy in anti-neutrophil cytoplasm antibody vasculitis.Determining the Incidence of Pneumocystis Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis.Avoidance of Harm From Treatment for ANCA-Associated Vasculitis.
P2860
Q24791788-404FBE73-7F4B-4829-B208-E868D72A6673Q26781920-BF966321-DE1F-40DA-953C-9287943652DEQ28393792-91ED8797-3095-43FC-B9DE-CB332785B9E2Q33922238-F8594121-42BF-4B89-939A-EE5876DFD052Q34124711-68A4CF3C-4037-4F36-954A-2B95AA581A53Q34970288-098E7ACE-FA39-496C-AFFF-6B2E616868E8Q35008095-2AE2C9C3-8BFA-4217-9EEF-CCE87C73DC62Q35103662-9264A6F6-03FE-455D-898A-90C47812CD9CQ35920640-A4D0567F-912D-4A30-B518-901C84766479Q35940586-EE579DE6-45B2-4EAA-A65C-E531BBE1FB2BQ36574609-0C4C9A48-9320-4E51-B368-666D6440CD7DQ36933191-1C971CCC-9B87-4352-B7F0-8F6F074CD5FAQ37453850-94F1D4FB-D978-423C-B5B4-163C3BBE4343Q37690737-56F011DC-AF5C-4B95-9582-0DDFA560FC6EQ37859113-39EE956E-BB26-4CC1-90BA-81FE25036D62Q38316279-1FA0029F-140D-4B15-9357-BF17463D8358Q40074567-47576CBD-3452-41D7-B53D-61D273CD3BB3Q47105115-D941B333-26B3-40F5-96B3-0274560998A4
P2860
Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Pneumocystis carinii pneumonia ...... with Wegener's granulomatosis.
@ast
Pneumocystis carinii pneumonia ...... with Wegener's granulomatosis.
@en
Pneumocystis carinii pneumonia ...... with Wegener's granulomatosis.
@nl
type
label
Pneumocystis carinii pneumonia ...... with Wegener's granulomatosis.
@ast
Pneumocystis carinii pneumonia ...... with Wegener's granulomatosis.
@en
Pneumocystis carinii pneumonia ...... with Wegener's granulomatosis.
@nl
prefLabel
Pneumocystis carinii pneumonia ...... with Wegener's granulomatosis.
@ast
Pneumocystis carinii pneumonia ...... with Wegener's granulomatosis.
@en
Pneumocystis carinii pneumonia ...... with Wegener's granulomatosis.
@nl
P2093
P1476
Pneumocystis carinii pneumonia ...... with Wegener's granulomatosis.
@en
P2093
P304
P356
10.1164/AJRCCM.151.3.7881673
P407
P433
P577
1995-03-01T00:00:00Z